
Published 2024-09-02
Keywords
- diabetes mellitus,
- podcast,
- LMCC,
- hypoglycemic agents,
- insulin
How to Cite
Copyright (c) 2024 Meryem K. Talbo, Tricia M Peters, MPhil, PhD, MD, Susan Joanne Wang, MSc, MDCM, Esther SH Kang, MDCM, Renée-Claude Bider, BSc, Katherine Lan, BScH, Samy Amghar, Vanessa Ross, Masha (Maryia) Samuel, BSc, Khiran Arumugam, BSc, MSc, Jan Pack, BSc, MSc

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
Welcome to the McGill Journal of Medicine (MJM) LMCC review. This podcast series was created to aid medical students studying for the Canadian Medical Council (MCC)’s licensing exam. Each episode is created based on specific LMCC objectives and is divided into 2 parts. In part one we provide an overview of the topic with the help of experts in the field, followed by Part 2 where we review LMCC styled questions to help consolidate knowledge. In this episode, we welcome our expert advisor, Dr. Tricia Peters, Endocrinologist and Associate Professor in the Faculty of Medicine and Health Sciences at McGill University to complete our series on LMCC Objective 37-2: Diabetes Mellitus by speaking about antihyperglycemic agents. This episode was written by Susan Wang, Meryem Talbo and Dr. Tricia Peters, with feedback from the entire MJM Podcast Team.
Downloads
References
- Targets for Glycemic Control: https://guidelines.diabetes.ca/cpg/chapter8
- Nutrition Therapy: https://guidelines.diabetes.ca/cpg/chapter11
- Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update: https://guidelines.diabetes.ca/cpg/chapter-13-2020-update
- Links for Dr Peter’s works: https://pubmed.ncbi.nlm.nih.gov/?sort=date&size=200&term=Peters+TM&cauthor_id=31388772